NAEOTOM Alpha

The NAEOTOM Alpha with SOMARIS/10 syngo CT VB10 software is an advanced dual-source, photon-counting computed tomography system designed to enhance diagnostic imaging through improved hardware and innovative software features like ZeeFree cardiac reconstruction and multi-threshold acquisition. Its methodology focuses on delivering superior image quality, expanded clinical applications including low-dose lung cancer screening and interventional guidance, and optimized workflow efficiency through intelligent automation and enhanced user interfaces.

The NAEOTOM Alpha CT scanner system, with its new software version SOMARIS/10 syngo CT VB10, is a dual-source CT system employing photon-counting detector technology. Its primary purpose is to generate and process cross-sectional images of patients, aiding trained staff in diagnosis, treatment, diagnostic and therapeutic interventions, and for low-dose lung cancer screening in high-risk populations. The system utilizes two continuously rotating tube-detector systems and produces DICOM-formatted images. Key operational aspects include patient and data management, X-ray scan control, image reconstruction, and image evaluation, all managed by the syngo CT VB10 software platform, which also supports plugin interfaces for various post-processing applications commercially distributed by Siemens and other vendors. This iteration of the NAEOTOM Alpha introduces several hardware modifications, such as updated Tin Filtration technology, a redesigned FAST 3D Camera for patient positioning, and a Multi-Purpose (Vitus) Table with options for extended installation distance, potentially facilitating combined use with mobile C-arm systems. Software enhancements are significant, featuring the new 'ZeeFree' algorithm designed to improve cardiac image reconstruction by reducing stack misalignment artifacts through cycle-to-cycle border alignment. Modified software features include an optimized FAST Integrated Workflow, an enhanced myNeedle Guide with an automatic MyNeedle Detection algorithm (showing 90.76% detection success in bench tests), an improved myExam Companion for dynamic scan parameter adaptation (myExam Cockpit/myExam Compass), advanced Recon&GO with expanded inline post-processing capabilities (like Spectral Recon from photon-counting data and inline table/bone removal), updated CT View&GO for image visualization, superior Quantum Spectral Imaging (allowing T3D reconstructions with sharp kernels and monoenergetic images from 40-190 keV), refined Quantum HD Cardiac capabilities, Multi-Threshold Acquisition for data from different energy thresholds (T1-T4), and myExam Satellite for remote reconstruction. Non-clinical bench testing has been performed to validate these modifications, demonstrating comparable or improved accuracy, image quality (e.g., HD FoV improving visualization outside the standard 50cm scan field), and workflow efficiencies.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 'ZeeFree' cardiac reconstruction algorithm technically achieve cycle-to-cycle border alignment, and what are its specific performance metrics compared to standard cardiac reconstruction in challenging patient scenarios (e.g., arrhythmias, high heart rates)?; What are the quantitative improvements in image quality (e.g., spatial resolution, contrast-to-noise ratio, artifact reduction) and diagnostic information provided by the 'Quantum Spectral Imaging' and 'Quantum HD Cardiac' modes, particularly using the sharpest kernels (e.g., Qr89, Br98) and monoenergetic reconstructions from Quantumpeak mode?; Can the 'Multi-Threshold Acquisition' capability be leveraged to differentiate materials or tissue types beyond current spectral CT applications, and what is the impact of reconstructing T2, T3, and T4 threshold data on dose and image noise?; With the 'myNeedle Detection' algorithm achieving 90.76% detection success in bench tests, what is its performance in diverse clinical settings with varying needle types, patient anatomies, and imaging artifacts, and how does it adapt to challenging cases?; How does the integration of 'Scan&GO' and the enhanced 'FAST Integrated Workflow' with the modified FAST 3D camera impact overall scan time, patient throughput, and operator workload in a busy clinical environment?